A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues
- PMID: 171104
- DOI: 10.1016/0009-8981(75)90202-8
A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues
Abstract
A simple method for the determination of oestrogen receptor activity in breast tumours and other tissues is described. By competition between radioactive and non-radioactive oestradiol-17beta for binding to a tissue extract prepared with centrifugation at low speed, the presence or absence of receptors is decided from the unmanipulated data. The concentration of receptors (P0) and dissociation constant of binding (Kd) are calculated by Scatchard analysis. In two relatively homogeneous tissues, assay precision was of the order of 16% for receptor concentration and 21-33% for the dissociation constant of binding: in heterogeneous breast tumors, much poorer precision can be expected. Sensitivity determined empirically is approximately 0.1 fmol/mg tissue. The method has been applied to the determination of receptor concentrations in human breast cancers, benign breast tumours, non-malignant breast, gynaecomastic breast, and in various tissues of the rat. Receptor activity was detected in 70% of the human breast cancers examined, and in lower amounts, in 21% of the benign human breast tissues. Activity was also detected in rat uterus and mammary gland, and in low amounts in 82% of the rat mammary tumours analysed. Dissociation constant of binding was generally of the order of 0.5 x 10(-10) M. The advantages of the method are discussed.
Similar articles
-
Oestrogen receptor activity and intranuclear translocation of oestradiol in rat and human mammary tumours.J Endocrinol. 1983 Jul;98(1):91-102. doi: 10.1677/joe.0.0980091. J Endocrinol. 1983. PMID: 6864150
-
Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake.Breast Cancer Res Treat. 1997 Feb;42(3):215-26. doi: 10.1023/a:1005714312092. Breast Cancer Res Treat. 1997. PMID: 9065605
-
Kinetic data of cytoplasmic estradiol receptor.Endocrinol Exp. 1983 Mar;17(1):23-31. Endocrinol Exp. 1983. PMID: 6603347
-
Steroid-binding proteins of the mammary gland and their clinical significance in breast cancer.J Toxicol Environ Health Suppl. 1976;1:231-56. J Toxicol Environ Health Suppl. 1976. PMID: 186628 Review.
-
Oestrogen-binding and the hormone respinsiveness of tumours.Steroidologia. 1970;1(2):73-88. Steroidologia. 1970. PMID: 4938760 Review. No abstract available.
Cited by
-
The H-ras oncogene product p21 and prognosis in human breast cancer.Breast Cancer Res Treat. 1991 Jan-Feb;17(3):161-9. doi: 10.1007/BF01806365. Breast Cancer Res Treat. 1991. PMID: 2039838
-
Epidemiology and endocrinology of benign breast disease.Breast Cancer Res Treat. 1985;6(1):5-36. doi: 10.1007/BF01806008. Breast Cancer Res Treat. 1985. PMID: 3902125 Review.
-
Assessment of oestrogen receptor content of breast carcinoma by immunohistochemical techniques on fixed and frozen tissue and by biochemical ligand binding assay.J Clin Pathol. 1990 Jan;43(1):46-51. doi: 10.1136/jcp.43.1.46. J Clin Pathol. 1990. PMID: 2312751 Free PMC article.
-
Prostaglandins in human mammary cancer.Br J Cancer. 1984 Apr;49(4):459-64. doi: 10.1038/bjc.1984.73. Br J Cancer. 1984. PMID: 6585216 Free PMC article.
-
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines.Br J Cancer. 1990 Aug;62(2):213-6. doi: 10.1038/bjc.1990.263. Br J Cancer. 1990. PMID: 2386737 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources